ScholarIQanswers from OpenAlex & ORCID
Peter A. Johansson
ResearcherPublications, citations & collaboration network
Peter A. Johansson is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Peter A. Johansson have?
ScholarIQindexed works
Peter A. Johansson has 311 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Peter A. Johansson have?
ScholarIQcitation count
Peter A. Johansson has 30,977 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Peter A. Johansson?
ScholarIQh-index
Peter A. Johansson has an h-index of 60 in OpenAlex.
What is the i10-index of Peter A. Johansson?
ScholarIQi10-index
Peter A. Johansson has an i10-index of 121 in OpenAlex.
What is the ORCID of Peter A. Johansson?
ScholarIQorcid
The ORCID for Peter A. Johansson is on the source record.
What is the OpenAlex record for Peter A. Johansson?
ScholarIQopenalex
The OpenAlex for Peter A. Johansson is on the source record.
What are the most-cited papers on Peter A. Johansson?
ScholarIQmost cited works
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
Stephen D. Wiviott, Itamar Raz, Marc P. Bonaca, Ofri Mosenzon, Eri Kato, Avivit Cahn, Michael G. Silverman, Thomas A. Zelniker, Julia Kuder, Sabina A. Murphy, Deepak L. Bhatt, Lawrence A. Leiter, Darren K. McGuire, John Wilding, Christian T. Ruff, Ingrid Gause‐Nilsson, Martin Fredriksson, Peter A. Johansson, Anna-Maria Langkilde, Marc S. Sabatine
Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE–TIMI 58 randomised trial
Ofri Mosenzon, Stephen D. Wiviott, Avivit Cahn, Aliza Rozenberg, Ilan Yanuv, Erica L. Goodrich, Sabina A. Murphy, Hiddo J.L. Heerspink, Thomas A. Zelniker, Jamie P. Dwyer, Deepak L. Bhatt, Lawrence A. Leiter, Darren K. McGuire, John Wilding, Eri Kato, Ingrid Gause‐Nilsson, Martin Fredriksson, Peter A. Johansson, Anna Maria Langkilde, Marc S. Sabatine, Itamar Raz
Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus
Eri Kato, Michael G. Silverman, Ofri Mosenzon, Thomas A. Zelniker, Avivit Cahn, Remo H.M. Furtado, Julia Kuder, Sabina A. Murphy, Deepak L. Bhatt, Lawrence A. Leiter, Darren K. McGuire, John Wilding, Marc P. Bonaca, Christian T. Ruff, Akshay S. Desai, Shinya Goto, Peter A. Johansson, Ingrid Gause‐Nilsson, Per Johanson, Anna Maria Langkilde, Itamar Raz, Marc S. Sabatine, Stephen D. Wiviott